Fig. 1 · Structure

Documents & Downloads

CTAP

μ Opioid Receptor Antagonist

CTAP is a potent and highly selective μ opioid receptor antagonist, exhibiting an IC50 of 3.5 nM. It demonstrates over 1200-fold selectivity against δ opioid receptors (IC50 = 4500 nM) and somatostatin receptors. CTAP is valuable for research applications focusing on L-DOPA-induced dyskinesia, as well as studies related to opiate overdose and addiction mechanisms.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer Adooq Bioscience
Actions Antagonist
CAS Number 103429-32-9
Applications μ Opioid Receptor Antagonist
Formula C51H69N13O11S2
Molecular Weight 1104.30
SMILES
C[C@@H](O)[C@H](NC(=O)C1NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CSSC1(C)C)NC(=O)[C@H](N)Cc1ccccc1)[C@@H](C)O)C(N)=O

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...